🤝LIST & Cebi Group strengthen collaboration on advanced testing and characterization ℹ️ Building on three years of successful collaboration, the two entities have extended their partnership under the National Characterization and Testing Platform for another five years. Launched in 2022, the initiative combines: ▶ CEBI’s cutting-edge industrial laboratory inaugurated in 2021 ▶ LIST’s expertise for structural identification, failure investigation, and endurance testing, among others Together, this renewed agreement strengthens a unique framework in Luxembourg that delivers comprehensive materials characterization and testing services for industry and research alike. More information here 👉 https://lnkd.in/ePRTYUXb #Research #Innovation #MaterialsScience #Luxembourg
Luxembourg Institute of Science and Technology (LIST)’s Post
More Relevant Posts
-
The collaboration between NIBRT National Institute for Bioprocessing Research and Training, and SSPC builds on a strong history of successful joint initiatives, with a shared commitment to advancing innovative technologies that tackle critical challenges in the industry. The partnership marks a significant step forward in driving innovation and delivering transformative therapies within Ireland’s (bio)pharma sector. By combining our expertise and resources, we are well-positioned to accelerate scientific progress and nurture talent. Bringing together outstanding researchers and research groups from across Ireland’s academic landscape, united by a common goal. Read about this partnership, and other highlights from SSPC: ➡️https://lnkd.in/eMaipTzm Research Ireland University of Limerick #biopharmaceuticals #collaboration #Ireland #Talent
To view or add a comment, sign in
-
Our latest updates have been published in the August Update of the NSC Community: ⭐ Recap from our External Stakeholder #Webinar in June 2025, on the practical implementation of the Safe and Sustainable by Design (#SSbD) framework, with a strong focus on real-world industrial applications. ⭐ Interview series to WP leaders: Stephan Wagner, leading the work package on analytical methods for tailored requests. ⭐ The launch of the #SbD4Skin tool, a powerful, user-friendly platform that predicts whether chemicals may cause skin irritation, allergies, or toxicity—without the need for animal 🐰 testing. Grab a coffee☕and catch up with us!!
📬 The 8th NSC News & Events Update of 2025 has been released! Scroll through it to get the latest news from the NSC Community: 👉 Recaps of the NSC events this summer: NSC’s #SSbD session at #NN25 (10 July 2025, Thessaloniki, Greece) 👉 Several updates from the SSbD4CheM project (Recap from their External Stakeholder Webinar in June 2025, interview series to WP leaders, and launch of the #SbD4Skin tool) 👉 Website launch of the InnoMatSyn project – Interested in becoming a stakeholder? 👉 Scoping survey on Safety and Sustainability Trade-offs from the SUNRISE project 👉 MACRAMÉ Project Survey on the Draft recommendations on testing and assessment strategies for advanced materials 👉 From the PLANETS SSbD project, their SSbD wordbook and their latest training materials for conducting a SSbD Tier 2 assessment using #QSAR modelling, and an introduction to #FAIRdata and models, and the #DPP 👉 The latest newsletters from IAM-I, #nanoPASS, RELIANCE HE Project and CheMatSustain projects 👉 Additionally, new publications from the OECD - OCDE #WPMN. 👉 And many upcoming #events that you might want to attend! We are looking forward to meeting you in one of the next NSC events (e.g., SENTIATECH, 2nd NSC workshop on SSbD Scenarios, SSbD25, etc.)! Enjoy the reading 📰 https://lnkd.in/dQbT9nsp If you are not yet subscribed to the #NSC mailing list, sign up now and stay up to date: https://lnkd.in/djYk3ZW5
To view or add a comment, sign in
-
-
EUROLAB Secretary Laura Martin attended the IMEKO Joint Conference TC8-TC11-TC24 in Torino supported by ASSOTIC, EUROLAB, INRiM - Istituto Nazionale di Ricerca Metrologica and Politecnico di Torino. The conference started today, 15 September, gathering experts both from industry and academia, covering different topics such as ‘Traceability in Metrology’ (IMEKO TC8), ‘Measurement in Testing, Inspection and Certification’ (IMEKO TC11), and ‘Chemical Measurements’ (IMEKO TC24). The conference covers topics including certified reference materials, digitalisation in traceability, digital twins, and quality management & conformity assessment in the TIC Sector. In addition, issues related to climate change and energy transition will be examined with case studies and applied methodologies. Laura Martin represented EUROLAB in the opening ceremony, with key insights on our activities around the main EUROLAB priorities, digitalisation, sustainability, accreditation & standardisation and the European quality infrastructure, including project opportunities, parnerships, representation & sharing of best practices and technical expertise. EUROLAB is delighted to support this year's IMEKO conference and we look forward to continuing this fruitful cooperation. EURAMET - The European Association of National Metrology Institutes IMEKO - International Measurement Confederation Eurachem ASSOTIC HellasLab . Fenelab branchevereniging RELACRE-Associação de Laboratórios Acreditados de Portugal TURKLAB Eurolab-España Eurolab France NLA-SA (National Laboratory Association South Africa) EUROLAB-D Andreas Dr. Kinzel Laura Martin
To view or add a comment, sign in
-
-
📗 ECGI Working Paper "Common Ownership Directors" 👥 Authors - Ofer Eldar (University of California, Berkeley and ECGI) - Yaron Nili (Duke University and ECGI) - Yingze Xu (Washington University in St. Louis) 🔍 Read the full paper: https://lnkd.in/dyk8AM_a This paper develops a model in which common owners of firms within the same industry appoint a shared director to facilitate information-sharing between companies with similar products. While such collaboration increases the likelihood of product success, it also intensifies competition, leading to reduced profits. Empirically, the study finds that active, long-term common owners with sizable stakes, particularly in the pharmaceutical industry, are most likely to appoint common directors. Consistent with the theoretical model, these appointments are associated with greater product similarity and broader product scope, suggesting higher success rates, but also with lower markups and reduced innovation. 👉 Learn more about ECGI and its research: https://www.ecgi.global/ 💡 Explore the ECGI Working Paper Series: https://lnkd.in/gg7YArgs #ECGIwp #CorporateGovernance SSRN
To view or add a comment, sign in
-
-
Like many others, I was truly delighted to attend the IRCOBI conference and exchange ideas with safety professionals from all corners of the world. It's always a pleasure to engage in both scientific and informal discussions within such a friendly and enthusiastic atmosphere. From this 2025 conference, my key takeaways are: - The Virtual Testing project is clearly keeping many people busy, likely due to tight deadlines! * Among other challenges, establishing a standardized workflow, from pre-processing to post-processing, still needs to be addressed. * While many Human Body Models (HBMs) appear to be quite effective (see Florent Auriault et al. in the proceedings ;-), experimental data input remains critical for accurate injury prediction. * However, to account for the wide diversity of human morphologies, a "fair enough" status for HBMs might suffice to provide valuable insights for safety system manufacturers. - Anthropomorphic Test Devices (ATDs) are far from obsolete, continuing to benefit from new experimental data and innovative advancements. I very much look forward to crossing paths with you again, whether through scientific research projects or future conferences!
To view or add a comment, sign in
-
At SafePoint Scientific, the mission goes beyond delivering reliable lab equipment — it’s about enabling breakthrough work in environments where accuracy and safety can't be compromised. Whether it's biotech, pharma, healthcare, or academic research, SafePoint supports innovation by providing calibrated instruments, expert guidance, and a commitment to excellence. Every detail matters when advancing science, and SafePoint is setting the bar high — with tools and support that keep labs running smoothly and securely. Learn more: https://lnkd.in/eCgmr6GX #LabSafety #ScientificInnovation #Biotech #PrecisionMatters #SafePointScientific
Setting the standard for safety and precision in every lab. 🔬 At SafePoint Scientific, we believe that every breakthrough in science should be built on a foundation of trust, safety, and uncompromising precision. From cutting-edge solutions to expertly calibrated instruments, we provide the tools, expertise, and support that keep labs, research facilities, and production environments running flawlessly. 🌟 Serving industries from biotech and pharma to healthcare and academic research, we’re here to empower innovation, while keeping safety at the forefront. Follow along for insights, innovations, and the future of lab safety and precision. 🌐 Learn more at: https://lnkd.in/eCgmr6GX
To view or add a comment, sign in
-
-
Today marks the start of the first analytica USA 2025 International Trade Fair at the Greater Columbus Convention Center, Columbus, Ohio. Eagerly awaited by the world’s scientific community as a Stateside complement to the established European show, Analytica USA is set to bring together the scientific community of lab technology, analysis, biotechnology and diagnostics on the global stage. Visit us at Booth 1349 in Exhibit Hall B, to meet our team: Vivi Wei Wang, Account Manager, North America; Amir Yeganeh, Application Scientist; Priscilla P., Account Manager Inside Sales; and Sanji Bhal, Director of Marketing and Communications, to learn more about desktop or browser-based deployment options of ACD/Labs Spectrus Platform. ACD/Labs provides software solutions for analytical data handling in R&D, capable of processing, analyzing, and sharing data from all techniques and formats. Our tools deliver chemically intelligent analysis, integrate chemical structures, and enable data annotation. Read more on how ACD/Labs can help digitalize your lab: https://lnkd.in/gjPhCQKJ #AnalyticaUSA2025 #LaboratoryTechnology #Biotechnology #Lifesciences
To view or add a comment, sign in
-
-
Growth data is clear: Company A targets high growth segments. Company B stays in mature markets. -> Company A is 3 time more likely to gain share. Same effort, different odds. More at Ilmac next week - ECLIPSAI growth strategy for Life Science Tools & Services.
To view or add a comment, sign in
-
On a Roll ⏩ With a multimillion grant from NordForsk, new life science consortium NordicPharmaTrain consolidates the ties between ten of the Nordics' top-ranked universities ✅ "With NordForsk's generous support, we are all set to take on the entire process from manufacturing and delivery of drugs to clinical implementation" states Christel Bergström, Project Leader & Professor at Uppsala University 💊 Visit NordicPharmaTrain online • https://lnkd.in/gQe4SkBv ✅ Read Full Story 👉 https://lnkd.in/dye9Uj3i
To view or add a comment, sign in
-
-
Accelerating Innovation in Michigan: A Look at TSRL, Inc. TSRL, Inc., a proud member of the Michigan Business Innovation Association (MBIA), is helping academic research teams turn groundbreaking concepts into viable therapies with its program, "The Accelerator." This isn't your average program. It combines industry expertise, business strategy, and real-world infrastructure to de-risk drug product development. They offer a blend of scientific guidance and commercial know-how, and even help secure funding—they've assisted with over $21 million in grants! What truly sets them apart is their physical infrastructure, including 5,000 sq. ft of wet lab space and state-of-the-art animal laboratories. This allows teams to generate crucial data on-site, accelerating the path from a concept to a licensing-ready asset. "The Accelerator" is bridging the gap between innovation and commercialization, fast-forwarding the future of drug therapy in our state and beyond. Find out more here: https://lnkd.in/gx2fJApm
To view or add a comment, sign in
At Cebi Group we are proud to extend our collaboration with LIST, combining industrial expertise and scientific excellence to strengthen Luxembourg’s unique testing and characterization ecosystem. 🤝